Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay)
Yanjun Hou; Gary Tozbikian; Debra L. Zynger; Zaibo Li
Author Information: From the Department of Pathology, The Ohio State University Wexner Medical Center, Columbus
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.